Detalhe da pesquisa
1.
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
Br J Haematol
; 196(6): 1369-1380, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954822
2.
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Blood
; 135(21): 1859-1869, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267500
3.
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
BMC Geriatr
; 21(1): 320, 2021 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011271
4.
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Blood
; 131(22): 2413-2425, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29449275
5.
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Haematologica
; 105(2): 448-456, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371416
6.
Diffuse large B-cell lymphoma genotyping on the liquid biopsy.
Blood
; 129(14): 1947-1957, 2017 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096087
7.
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.
Hematol Oncol
; 40(5): 1105-1108, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35656838
8.
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.
Hematol Oncol
; 40(5): 1100-1104, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613703
9.
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.
Blood
; 123(14): 2139-47, 2014 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24501221
10.
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.
Blood
; 121(8): 1403-12, 2013 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23243274
11.
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
Blood
; 119(12): 2854-62, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308293
12.
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.
Br J Haematol
; 181(5): 693-695, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369711
13.
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation.
Blood
; 117(12): 3391-401, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21266718
14.
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.
Blood
; 118(26): 6904-8, 2011 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22039264
15.
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma.
Hematol Oncol
; 31(1): 22-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22488585
16.
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
Genes Chromosomes Cancer
; 50(8): 633-43, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21563234
17.
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.
Br J Haematol
; 154(5): 590-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21749360
18.
Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.
Haematologica
; 101(4): e135-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819056
19.
Genome wide DNA-profiling of HIV-related B-cell lymphomas.
Br J Haematol
; 148(2): 245-55, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19832807
20.
Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
Hematol Oncol
; 28(2): 62-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20014148